Dell and Xerox deals have healthcare angles

When someone says "healthcare M&A", the first thing that comes to mind might be the current round of pharma and biotech deals, which Pfizer Inc. (NYSE:PFE) kicked off in January with its $68 billion acquisition of Wyeth (NYSE:WYE).